- Home
- SRPT vs SOLV Comparison
SRPT vs SOLV Comparison
Compare SRPT & SOLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- SOLV
- Stock Information
- Founded
- SRPT 1980
- SOLV 2023
- Country
- SRPT United States
- SOLV United States
- Employees
- SRPT N/A
- SOLV N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- SOLV
- Sector
- SRPT Health Care
- SOLV
- Exchange
- SRPT Nasdaq
- SOLV NYSE
- Market Cap
- SRPT 1.7B
- SOLV 12.7B
- IPO Year
- SRPT 1997
- SOLV N/A
- Fundamental
- Price
- SRPT $17.97
- SOLV $73.75
- Analyst Decision
- SRPT Buy
- SOLV Hold
- Analyst Count
- SRPT 25
- SOLV 11
- Target Price
- SRPT $61.57
- SOLV $80.29
- AVG Volume (30 Days)
- SRPT 7.9M
- SOLV 792.3K
- Earning Date
- SRPT 08-06-2025
- SOLV 08-07-2025
- Dividend Yield
- SRPT N/A
- SOLV N/A
- EPS Growth
- SRPT N/A
- SOLV N/A
- EPS
- SRPT N/A
- SOLV 2.18
- Revenue
- SRPT $2,233,371,000.00
- SOLV $8,308,000,000.00
- Revenue This Year
- SRPT $26.87
- SOLV $4.11
- Revenue Next Year
- SRPT $3.15
- SOLV $0.14
- P/E Ratio
- SRPT N/A
- SOLV $33.91
- Revenue Growth
- SRPT 59.15
- SOLV 1.29
- 52 Week Low
- SRPT $16.88
- SOLV $47.16
- 52 Week High
- SRPT $154.13
- SOLV $85.92
- Technical
- Relative Strength Index (RSI)
- SRPT 28.43
- SOLV N/A
- Support Level
- SRPT $17.31
- SOLV N/A
- Resistance Level
- SRPT $19.74
- SOLV N/A
- Average True Range (ATR)
- SRPT 1.04
- SOLV 0.00
- MACD
- SRPT 0.87
- SOLV 0.00
- Stochastic Oscillator
- SRPT 45.83
- SOLV 0.00
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About SOLV SOLVENTUM CORP
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.